TY - JOUR T1 - Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina JF - Heart JO - Heart SP - 151 LP - 154 DO - 10.1136/hrt.2003.012062 VL - 90 IS - 2 AU - H J Ankersmit AU - T Weber AU - J Auer AU - G Roth AU - M Brunner AU - E Kvas AU - B Moser AU - S Spreitzer AU - E Lassnig AU - E Maurer AU - P Hartl AU - E Wolner AU - G Boltz-Nitulescu AU - B Eber Y1 - 2004/02/01 UR - http://heart.bmj.com/content/90/2/151.abstract N2 - Objectives: To investigate the expression of death inducing receptors in the sera of patients with stable and unstable angina. Design: 80 consecutive patients with stable (n  =  40) or unstable (n  =  40) angina pectoris were studied. Serum concentrations of soluble CD95 (sCD95), soluble CD95 ligand (sCD95L; CD178), tumour necrosis factor (TNF) α, soluble TNFα receptor type 1 (sTNFR1), and interleukin 1β converting enzyme (ICE; caspase 1) were measured by enzyme linked immunosorbent assay (ELISA). Results: Significant increases in the concentrations of sCD95 and ICE (p < 0.001 and p < 0.023, respectively) were found in the serum from patients with unstable angina relative to those with stable angina. There were no significant differences in the concentrations of sCD95L, TNF α, and sTNFR1 between the groups. Conclusions: These data provide the first evidence that sCD95 and ICE are important serological markers that may help to discriminate between stable and unstable angina. This observation may warrant further clinical study to elucidate the clinical impact of sCD95 and ICE in acute coronary syndromes. ER -